256 related articles for article (PubMed ID: 35490644)
1. Coagulation factors XI and XII as possible targets for anticoagulant therapy.
Kluge KE; Seljeflot I; Arnesen H; Jensen T; Halvorsen S; Helseth R
Thromb Res; 2022 Jun; 214():53-62. PubMed ID: 35490644
[TBL] [Abstract][Full Text] [Related]
2. Factor XI and contact activation as targets for antithrombotic therapy.
Gailani D; Bane CE; Gruber A
J Thromb Haemost; 2015 Aug; 13(8):1383-95. PubMed ID: 25976012
[TBL] [Abstract][Full Text] [Related]
3. New Therapeutic Targets for the Prevention and Treatment of Venous Thromboembolism With a Focus on Factor XI Inhibitors.
Chan NC; Weitz JI
Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):1755-1763. PubMed ID: 37650326
[TBL] [Abstract][Full Text] [Related]
4. The hemostatic role of factor XI.
Puy C; Rigg RA; McCarty OJ
Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S8-S11. PubMed ID: 27207433
[TBL] [Abstract][Full Text] [Related]
5. The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials.
DeLoughery EP; Olson SR; Puy C; McCarty OJT; Shatzel JJ
Semin Thromb Hemost; 2019 Jul; 45(5):502-508. PubMed ID: 31216587
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology and Clinical Development of Factor XI Inhibitors.
Greco A; Laudani C; Spagnolo M; Agnello F; Faro DC; Finocchiaro S; Legnazzi M; Mauro MS; Mazzone PM; Occhipinti G; Rochira C; Scalia L; Capodanno D
Circulation; 2023 Mar; 147(11):897-913. PubMed ID: 36913497
[TBL] [Abstract][Full Text] [Related]
7. Factor XI and factor XII as targets for new anticoagulants.
Weitz JI
Thromb Res; 2016 May; 141 Suppl 2():S40-5. PubMed ID: 27207423
[TBL] [Abstract][Full Text] [Related]
8. Factor XI and coagulation. Factor XI inhibitors - antithrombotic perspectives.
Vlădăreanu AM; Roşca A
Rom J Intern Med; 2024 Jun; 62(2):91-100. PubMed ID: 38153875
[TBL] [Abstract][Full Text] [Related]
9. Regulation of blood coagulation factors XI and XII in patients with acute and chronic cerebrovascular disease: a case-control study.
Kraft P; Drechsler C; Gunreben I; Heuschmann PU; Kleinschnitz C
Cerebrovasc Dis; 2014; 38(5):337-43. PubMed ID: 25427539
[TBL] [Abstract][Full Text] [Related]
10. [New perspective of anticoagulation in intensive care unit: basic and clinical advances in coagulation factor XII and XI inhibitors].
Wang R; Yang Z; Ma S; Zhu F
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Jan; 36(1):16-22. PubMed ID: 38404266
[TBL] [Abstract][Full Text] [Related]
11. Emerging anticoagulant strategies.
Fredenburgh JC; Gross PL; Weitz JI
Blood; 2017 Jan; 129(2):147-154. PubMed ID: 27780803
[TBL] [Abstract][Full Text] [Related]
12. The rebirth of the contact pathway: a new therapeutic target.
Srivastava P; Gailani D
Curr Opin Hematol; 2020 Sep; 27(5):311-319. PubMed ID: 32740037
[TBL] [Abstract][Full Text] [Related]
13. Epidemiologic and clinical data linking factors XI and XII to thrombosis.
Key NS
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):66-70. PubMed ID: 25696836
[TBL] [Abstract][Full Text] [Related]
14. Factor XI and XII as antithrombotic targets.
Müller F; Gailani D; Renné T
Curr Opin Hematol; 2011 Sep; 18(5):349-55. PubMed ID: 21730835
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk.
Zhang H; Löwenberg EC; Crosby JR; MacLeod AR; Zhao C; Gao D; Black C; Revenko AS; Meijers JC; Stroes ES; Levi M; Monia BP
Blood; 2010 Nov; 116(22):4684-92. PubMed ID: 20807891
[TBL] [Abstract][Full Text] [Related]
16. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic targeting of coagulation factors XII and XI by monoclonal antibodies reduces thrombosis in nitinol stents under flow.
Keeling NM; Wallisch M; Johnson J; Le HH; Vu HH; Jordan KR; Puy C; Tucker EI; Nguyen KP; McCarty OJT; Aslan JE; Hinds MT; Anderson DEJ
J Thromb Haemost; 2024 May; 22(5):1433-1446. PubMed ID: 38331196
[TBL] [Abstract][Full Text] [Related]
18. Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Undergoing Central Line Placement: A Phase 2 Clinical Trial.
Pfeffer MA; Kohs TCL; Vu HH; Jordan KR; Wang JSH; Lorentz CU; Tucker EI; Puy C; Olson SR; DeLoughery TG; Hinds MT; Keshari RS; Gailani D; Lupu F; McCarty OJT; Shatzel JJ
Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):290-299. PubMed ID: 37970718
[TBL] [Abstract][Full Text] [Related]
19. Factor XI antisense oligonucleotide for prevention of venous thrombosis.
Büller HR; Bethune C; Bhanot S; Gailani D; Monia BP; Raskob GE; Segers A; Verhamme P; Weitz JI;
N Engl J Med; 2015 Jan; 372(3):232-40. PubMed ID: 25482425
[TBL] [Abstract][Full Text] [Related]
20. Coagulation factor XI as a novel target for antithrombotic treatment.
Löwenberg EC; Meijers JC; Monia BP; Levi M
J Thromb Haemost; 2010 Nov; 8(11):2349-57. PubMed ID: 20727068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
